PPARG and Parkinson disease: For instance, in the onset and disease progression of PD, expression of PPARγ is attenuated along with activated cell death and upregulated oxidative stress, which can be reversed by PPARγ agonists, indicating the neuroprotective role of this transcription factor (Schintu et al., 2009; Falcone et al., 2015).